Role of cytokines in heart failure (Q41715870)

7 October 2017

1 reference

title

Role of cytokines in heart failure (English)

1 reference

7 October 2017

0 references

Blum A

1

1 reference

7 October 2017

Miller H

series ordinal

2

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

7 October 2017

published in

American Heart Journal

1 reference

7 October 2017

volume

135

1 reference

7 October 2017

issue

2 Pt 1

1 reference

7 October 2017

page(s)

181-186

1 reference

The management of chronic heart failure

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Intact systolic left ventricular function in clinical congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Plasma norepinephrine in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Controlled trials with beta blockers in heart failure: metoprolol as the prototype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

TNF-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Activation of Ca-permeable cation channels by myocarditis-associated antibody in guinea pig ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Increased circulating cytokines in patients with myocarditis and cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Cytokines and endothelial cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Endomyocardial biopsy pathology in insulin-dependent diabetic patients with abnormal ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Effect of diabetes on metabolic coronary dilatation in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Effects of hypoxia and adrenergic stimulation induced alterations in PGI2 synthesis by diabetic coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Comparative vasoactive effects of native and synthetic atrial natriuretic factor (ANF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

HL-A and hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Cardiotoxicity of antitumor agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Immunologic dialogue between cardiac myocytes, endothelial cells, and mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Beneficial effects of metoprolol treatment in congestive heart failure. Reversal of sympathetic-induced alterations of immunologic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2898%2970080-8

10.1016/S0002-8703(98)70080-8

7 January 2021

Identifiers

DOI

1 reference

7 October 2017

1 reference